Research and development as well as office space has been established on behalf of Novozymes in a location called Whitefield in what is the capital and largest city in the south-west Indian state of Karnataka.
The new Bangalore office space and R&D facility are seen as a strategically important development for the company, which is the largest of its kind in India and supplies enzymes to aid the production of various oils, fats, beverages and foods across the subcontinent.
“Our Indian management team has found a facility that can accommodate both the needs of the Indian business in order to deliver on our growth promise and the growing demand for global shared services,” said GS Krishnan, Novozymes’ regional president for India.
“We believe that this space creates a prominent landmark for Novozymes in India and is geared to accommodate the growth of Novozymes in India in coming years.”
A variety of administrative and managerial work is to take place at the company’s new office space in Bangalore and its bosses have noted the remarkable progress made since it first started working in India with just two employees and a single business centre back in 1983.
Last month, a report from the global real estate analyst firm Cushman & Wakefield suggested that Bangalore will see the greatest levels of demand for office space in India over the course of the next five years, ahead of Mumbai, New Delhi and Chennai.
Editor’s notes: In May 2023, Novozymes’ India office was listed as Prestige Featherlite Tech Park, Whitefield, Vijayanagar, EPIP Zone, Bengaluru, Karnataka, on its corporate website.
The biotechnology company holds its global headquarters on the outskirts of Copenhagen in Denmark and in April 2023 announced that it had delivered stronger results than expected with 5% organic sales growth, in the first quarter of the year.